Thank you.
Thank you to all the witnesses for being here or speaking here.
I would like to start with Dr. Turcotte.
You talked about the challenges facing Canada and the world in the production of medical isotopes—the rising costs, the coordination needed—and the challenges around production if something shut down. There might be shortages. Could you expand on what you think is the best system or the best program that Canada can move forward with to provide a stable supply of isotopes for our country and, perhaps, for the world, which is a role we used to play?